These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9600718)

  • 1. Pharmacokinetic assessment of the sites of first-pass metabolism of BMS-181101, an antidepressant agent, in rats.
    Vachharajani NN; Shyu WC; Shah VR; Barbhaiya RH
    J Pharm Pharmacol; 1998 Mar; 50(3):275-8. PubMed ID: 9600718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pharmacokinetics, brain levels and protein binding of centpropazine in rats.
    Bhattaram VA; Paliwal JK; Gupta RC
    Biopharm Drug Dispos; 2004 Mar; 25(2):69-75. PubMed ID: 14872554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of age, gender, and diurnal variation on the steady-state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects.
    Srinivas NR; Shyu WC; Gleason C; Schuster A; Greene DS; Barbhaiya RH
    Clin Pharmacol Ther; 1997 Oct; 62(4):408-16. PubMed ID: 9357392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of food on the steady state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects.
    Srinivas NR; Shyu WC; Lee J; Greene DS; Barbhaiya RH
    Biopharm Drug Dispos; 1997 Oct; 18(7):585-93. PubMed ID: 9330779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG
    J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of radiolabeled BMS-204352 in rats and dogs.
    Krishna R; Yao M; Srinivas NR; Shah V; Pursley JM; Arnold M; Vachharajani NN
    Biopharm Drug Dispos; 2002 Jan; 23(1):41-6. PubMed ID: 11891672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics.
    Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S
    Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusion.
    Peng B; Dutreix C; Mehring G; Hayes MJ; Ben-Am M; Seiberling M; Pokorny R; Capdeville R; Lloyd P
    J Clin Pharmacol; 2004 Feb; 44(2):158-62. PubMed ID: 14747424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.
    Shin HS; Bae SK; Lee MG
    Int J Pharm; 2006 Aug; 320(1-2):64-70. PubMed ID: 16730145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein plays a role in the oral absorption of BMS-387032, a potent cyclin-dependent kinase 2 inhibitor, in rats.
    Kamath AV; Chong S; Chang M; Marathe PH
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):110-6. PubMed ID: 15338193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of gut and hepatic first-pass effect of drugs: 1. Studies of verapamil in ported dogs.
    Lee YH; Perry BA; Lee HS; Kunta JR; Sutyak JP; Sinko PJ
    Pharm Res; 2001 Dec; 18(12):1721-8. PubMed ID: 11785692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the first-pass metabolism of ebastine in rats.
    Fujii T; Matsumoto S; Hatoyama T; Miyazaki H
    Arzneimittelforschung; 1997 Aug; 47(8):949-53. PubMed ID: 9296281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
    Kim SH; Lee MG
    Life Sci; 2002 Feb; 70(11):1299-315. PubMed ID: 11883708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver and gastrointestinal first-pass effects of azosemide in rats.
    Kim J; Kim SH; Lee MG
    J Pharm Pharmacol; 1997 Sep; 49(9):878-83. PubMed ID: 9306255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gut contents, intestinal wall, and liver on the first pass metabolism and absolute bioavailability of isotretinoin in the dog.
    Cotler S; Buggé CJ; Colburn WA
    Drug Metab Dispos; 1983; 11(5):458-62. PubMed ID: 6138231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Absorption and organ distribution of the new antidepressant azaphen].
    Siniukhin VN
    Farmakol Toksikol; 1973; 26(4):409-11. PubMed ID: 4789881
    [No Abstract]   [Full Text] [Related]  

  • 18. Sites of first-pass bioactivation (hydrolysis) of orally administered zofenopril calcium in dogs.
    Morrison RA; Burkett DE; Arnold ME; D'Arienzo CJ; Weinstein SH
    Pharm Res; 1991 Mar; 8(3):370-5. PubMed ID: 2052527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the disposition of a novel p38 MAPK inhibitor, AKP-001, and its metabolites in rats with a simple physiologically based pharmacokinetic model.
    Shirota K; Kaneko M; Sasaki M; Minato K; Fujikata A; Ohta S; Hisaka A; Suzuki H
    Drug Metab Dispos; 2015 Feb; 43(2):217-26. PubMed ID: 25422274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonist.
    Vachharajani NN; Yeleswaram K; Boulton DW
    J Pharm Sci; 2003 Apr; 92(4):760-72. PubMed ID: 12661062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.